These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11020774)

  • 21. 10 % fluorescein sodium vs 1 % isosulfan blue in breast sentinel lymph node biopsy.
    Ren L; Liu Z; Liang M; Wang L; Song X; Wang S
    World J Surg Oncol; 2016 Nov; 14(1):280. PubMed ID: 27809854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer.
    Cinar H; Koca B; Kesicioglu T; Karabulut K; Karabicak I; Polat C; Tur AH
    Breast; 2012 Apr; 21(2):220-2. PubMed ID: 22186354
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dangerous blue?].
    Varhaug JE
    Tidsskr Nor Laegeforen; 2011 May; 131(8):842. PubMed ID: 21556091
    [No Abstract]   [Full Text] [Related]  

  • 24. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.
    Raut CP; Hunt KK; Akins JS; Daley MD; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
    Cancer; 2005 Aug; 104(4):692-9. PubMed ID: 15981283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blue dye of choice for lymphatic mapping.
    Vargas HI
    J Clin Oncol; 2005 May; 23(15):3648; author reply 3648-9. PubMed ID: 15908691
    [No Abstract]   [Full Text] [Related]  

  • 26. Oximetry and patent blue five dye.
    McEwan D; Lam K
    Anaesth Intensive Care; 1997 Oct; 25(5):587-8. PubMed ID: 9352783
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection.
    Martínez-Palones JM; Gil-Moreno A; Pérez-Benavente MA; Roca I; Xercavins J
    Gynecol Oncol; 2004 Mar; 92(3):845-50. PubMed ID: 14984951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isosulfan blue causes factitious methemoglobinemia in an infant.
    Burgoyne LL; Jay DW; Bikhazi GB; De Armendi AJ
    Paediatr Anaesth; 2005 Dec; 15(12):1116-9. PubMed ID: 16324035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulse oximetry declines due to intradermal isosulfan blue dye: a controlled prospective study.
    Momeni R; Ariyan S
    Ann Surg Oncol; 2004 Apr; 11(4):434-7. PubMed ID: 15070605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference of patent blue V dye with pulse oximetry and co-oximetry.
    Hueter L; Schwarzkopf K; Karzai W
    Eur J Anaesthesiol; 2005 Jun; 22(6):475-6. PubMed ID: 15991515
    [No Abstract]   [Full Text] [Related]  

  • 31. Blue dye is sufficient for sentinel lymph node biopsy in breast cancer.
    Ang CH; Tan MY; Teo C; Seah DW; Chen JC; Chan MY; Tan EY
    Br J Surg; 2014 Mar; 101(4):383-9; discussion 389. PubMed ID: 24492989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic reactions to isosulfan blue in sentinel lymph node mapping.
    Komenaka IK; Bauer VP; Schnabel FR; Horowitz E; Joseph KA; Ditkoff BA; El-Tamer MB
    Breast J; 2005; 11(1):70-2. PubMed ID: 15647083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subareolar versus peritumoral injection for location of the sentinel lymph node.
    Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
    Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative false negative rate of isosulfan blue in detecting sentinel lymph nodes in early breast cancer.
    Kantaraksa N; Kongdan Y; Suvikapakornkul R; Wasutit Y; Chirappapha P; Lertsithichai P
    J Med Assoc Thai; 2012 Feb; 95(2):181-5. PubMed ID: 22435247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of nonpalpable breast lesions using hook-wire combined with isosulfan blue dye.
    Zografos GC; Doumitriou C; Lappas D; Karatzikos G; Bami E; Fotiadis C; Menenakos E; Androulakis G
    J Surg Oncol; 2003 Jan; 82(1):73-4. PubMed ID: 12501171
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
    Mullan MH; Deacock SJ; Quiney NF; Kissin MW
    Eur J Surg Oncol; 2001 Mar; 27(2):218-9. PubMed ID: 11289765
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of radioisotope combined with isosulfan Blue dye is not superior to radioisotope alone for the identification of sentinel lymph nodes in patients with breast cancer.
    Bines S; Kopkash K; Ali A; Fogg L; Wool N
    Surgery; 2008 Oct; 144(4):606-9; discussion 609-10. PubMed ID: 18847645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
    Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
    J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping.
    Kaufman G; Guth AA; Pachter HL; Roses DF
    Am Surg; 2008 Feb; 74(2):152-5. PubMed ID: 18306869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
    Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
    Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.